Evidence map›Paper›PMID 38102072›Full record

ArticleJournal of investigative medicine high impact case reports

The Cancer Diaspora: A Rare Case of Pseudomyxoma Peritonei of Appendiceal Origin.

Lefika Bathobakae, Sacide S Ozgur, Mohita Jariwala, Jaydev Kesrani, Shajla Ajas, Mehandar Kumar, Amer Akmal

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 62% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lefika BathobakaeSt. Joseph's University Medical Center, Paterson, NJ, USA.ORCID 0000-0002-2772-6085
Sacide S OzgurSt. Joseph's University Medical Center, Paterson, NJ, USA.
Mohita JariwalaRowan University School of Osteopathic Medicine, Stratford, NJ, USA.
Jaydev KesraniSt. Joseph's University Medical Center, Paterson, NJ, USA.
Shajla AjasSt. Joseph's University Medical Center, Paterson, NJ, USA.
Mehandar KumarSt. Joseph's University Medical Center, Paterson, NJ, USA.
Amer AkmalSt. Joseph's University Medical Center, Paterson, NJ, USA.
St. Joseph’s University Medical Center · USRowan University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by widespread mucinous implants in the peritoneal cavity. Commonly seen in females in their 50s, PMP typically originates from ruptured appendiceal mucoceles that find refuge in the peritoneal space. Rarely, PMP may originate from the ovary, stomach, colon, or pancreas. Pseudomyxoma peritonei of colorectal origin is more malignant and has a lower survival rate. We report a case of a 59-year-old Hispanic woman with PMP who presented to the emergency room with a 3-month history of progressive abdominal distention. Pseudomyxoma peritonei was confirmed by computed tomography (CT) scan of the abdomen and pelvis and histopathology, and the patient underwent partial cytoreductive surgery. Given her Eastern Cooperative Oncology Group (ECOG) performance status of 1 despite extensive carcinomatosis, our patient may benefit from hyperthermic intraperitoneal chemotherapy (HIPEC) in the future.

Indexed as

Appendiceal NeoplasmsPeritoneal NeoplasmsPseudomyxoma PeritoneiFemaleHumansMiddle AgedMucocelecomplete cytoreductive therapyhyperthermic intraperitoneal chemotherapyjelly bellymucinous ascitesPseudomyxoma peritonei

Identifiers

PMID38102072
PMCPMC10725096
OpenAlexW4389804508

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.